ABL1 and lung adenocarcinoma: Notably, ABL allosteric inhibitors have also been shown to be efficacious in preclinical mouse models of breast and lung cancer metastasis, as treatment with GNF5 or ABL001 decreased lung adenocarcinoma metastasis to the brain and breast cancer metastasis to the bone [4, 6, 11].